Trending...
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
FAYETTEVILLE, Ark. & SEATTLE - ncarol.com -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network with the addition of CoMedical, a vascular access distribution company that services the Pacific Northwest. CoMedical, founded in 1980 and headquartered in Seattle Washington, is a medical device distributor specializing in the distribution and sale of vascular access products. CoMedical's sales team consisting of 6 members services Alaska, Idaho, Montana, Oregon and Washington on behalf of Lineus Medical.
"CoMedical is excited to be a partner with Lineus Medical in distributing SafeBreak Vascular in the Pacific Northwest. We are constantly reviewing the competitive landscape and searching for innovative products that we believe will bring tremendous value to our hospital clients and to their patients. SafeBreak Vascular fits that mold, and we believe it will improve peripheral IV access - the life line for many patients.", said Alison Donsky, Principal at CoMedical.
Vance Clement, CEO of Lineus Medical stated, "Launching a new class of medical device is hard work. CoMedical is a well experienced and nationally respected vascular access distribution company with a long history of success. Having CoMedical represent Lineus Medical and SafeBreak Vascular in the Pacific Northwest creates a win-win opportunity for both our companies. Lineus Medical is excited about the strong customer relationships that CoMedical brings to the table, and CoMedical understands the value of having a new and innovative product in their product portfolio."
More on ncarol.com
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a January 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually.
More on ncarol.com
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
MKG-0104
1D.I.P.P.E.R Study - Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
"CoMedical is excited to be a partner with Lineus Medical in distributing SafeBreak Vascular in the Pacific Northwest. We are constantly reviewing the competitive landscape and searching for innovative products that we believe will bring tremendous value to our hospital clients and to their patients. SafeBreak Vascular fits that mold, and we believe it will improve peripheral IV access - the life line for many patients.", said Alison Donsky, Principal at CoMedical.
Vance Clement, CEO of Lineus Medical stated, "Launching a new class of medical device is hard work. CoMedical is a well experienced and nationally respected vascular access distribution company with a long history of success. Having CoMedical represent Lineus Medical and SafeBreak Vascular in the Pacific Northwest creates a win-win opportunity for both our companies. Lineus Medical is excited about the strong customer relationships that CoMedical brings to the table, and CoMedical understands the value of having a new and innovative product in their product portfolio."
More on ncarol.com
- Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
- L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a January 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually.
More on ncarol.com
- Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
- KeysCaribbean Resorts Offer Savings On Summer Vacations Now Through Aug. 31
- Crossroads4Hope Announces The Lipschutz Women's Fund
- Handmade Coverlet Returns Home to Piedmont Crossing
- AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
MKG-0104
1D.I.P.P.E.R Study - Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on ncarol.com
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- NVM Pet Announces Leadership Transition, Promotes Next Generation of Executive Leadership
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Valgar LLC Launches The Briefing Room: Education Leaders
- New from Regal House Publishing, St. Ulphia's Dead, a dark comedy in the magical realist tradition
- New Novel WINCE Takes Unflinching Aim at American Gun Culture and Masculinity
- New Research Puts the Cost of Enterprise Decision Delay at $630 Billion a Year Across the Global 2000
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
- New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
- Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
- First Flight Society Celebrates National Aviation Day 2026 on Wednesday, August 19th
- Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
- Nina Simone and Samuel Waymon Music Scholarship Fund Opens 2026/27 Application Cycle
- Fatal FOMO May be Your Last Roll of the Dice
- Inlow Upholstery Offers Dining Chair Reupholstery for Cleveland County Homeowners
- Financial Visionary Kevin Foushee Expands Impact Through MTM LLC and Client-First Advisory Services
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board